Rectal Cancer
📧 Sign up to get email alerts when something new happens for Rectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Chemoradiation or Brachytherapy for Rectal Cancer [Phase 2]
Phase 2 trial evaluating chemoradiation or brachytherapy for rectal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: PET/MR for Rectal Cancer Treatment Monitoring and Surveillance [NA]
A terminated clinical trial evaluating PET/MR for monitoring and surveillance in rectal cancer; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial [Phase 2]
A Phase 2 pilot trial examining exercise during neoadjuvant chemoradiation to improve outcomes in rectal and esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer [Phase 2]
Phase 2 trial comparing mFOLFOX6 alone versus mFOLFOX6 combined with aflibercept as neoadjuvant therapy for MRI-defined T3 rectal cancer; st…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial [Phase 3]
Phase 3 RAPIDO trial in rectal cancer evaluating pre-operative induction therapy followed by dedicated surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer [Phase 2]
Phase 2 trial evaluating a PD-1 antibody after preoperative chemoradiotherapy in locally advanced pMMR/MSS rectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status [Phase 3]
Phase III trial investigating anus-preservation in low rectal adenocarcinoma based on MMR/MSI status involving toripalimab and radiation.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Enhanced Recovery After Laparoscopic Colorectal Surgery [Phase 4]
Phase 4 clinical trial update on enhanced recovery after laparoscopic colorectal surgery for rectal cancer, focusing on postoperative pain o…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy treatment followed by chemo and radiotherapy in locally advanced rectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating irinotecan plus E7820 versus FOLFIRI in second-line locally advanced or metastatic colon or rectal cancer; study …
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer [Phase 2]
Phase 2 trial evaluating short-course radiation therapy followed by neoadjuvant chemotherapy and surgery in locally advanced rectal cancer h…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis [Phase 2]
Phase 2 trial evaluating a combination therapy including anti-PD-1 immunotherapy for advanced rectal cancer with distal metastasis.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant Fruquintinib combined with concurrent chemoradiotherapy for locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esopha…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Developing and Evaluating Product Messaging [NA]
A completed clinical trial focusing on developing and evaluating product messaging for cancer of the colon and rectum; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Induction Chemotherapy for Locally Recurrent Rectal Cancer [Phase 3]
Phase 3 clinical trial update evaluating induction chemotherapy for locally recurrent rectal cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer [Phase 2]
Phase 2 clinical trial evaluating a bevacizumab-containing regimen before surgery for stage II-III rectal cancer; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating short-course radiotherapy followed by chemotherapy and a PD-1 inhibitor for locally advanced rectal ca…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer [Phase 3]
Phase 3 trial update examining whether lengthening the interval between radiochemotherapy and surgery affects complete pathological response…
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Rosuvastatin in the Treatment of Rectal Cancer [Phase 2]
Phase 2 clinical trial evaluating rosuvastatin for rectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating peposertib in combination with capecitabine and radiotherapy in locally advanced rectal cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Ploidy and Stroma in Early Rectal Cancer
Clinical trial update on ploidy and stroma in early rectal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer [NA]
Feasibility study update on sentinel lymph node biopsy in rectal cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™ [Phase 3]
Phase 3 randomized trial evaluating INTERCEED in rectal cancer surgery with preventive ileostomy; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM [Phase 3]
Phase 3 randomized trial investigating primary surgery followed by selective radiochemotherapy for rectal cancer with MRI-negative circumfer…